Peaberry Kona Coffee (Coffea arabica)

Peaberry Kona coffee contains approximately 12 mg caffeine per gram dry mass along with chlorogenic acids and caffeic acid. The caffeine acts as an adenosine receptor antagonist to promote alertness, though no clinical trials exist specifically for peaberry varieties.

Origin & History

Peaberry Kona Coffee is a rare variant of Coffea arabica cultivated in Hawaii's Kona region, where only 3-5% of coffee cherries develop a single, rounded pea-shaped bean instead of two flat seeds. These unique beans are sorted during hulling and contain typical arabica compounds including caffeine (~12 mg/g), chlorogenic acids, and phenolics identified through mass spectrometry.

Historical & Cultural Context

Peaberry Kona Coffee lacks documented historical use in traditional medicine systems and is primarily valued as a modern agricultural variant for its unique bean shape and flavor profile in Kona coffee production. While Coffea arabica originated in Ethiopian forests, no peaberry-specific traditional medicinal applications are referenced.

Health Benefits

• No documented health benefits from clinical trials - research limited to analytical chemistry and authentication methods
• Contains caffeine (~12 mg/g dry mass) associated with general coffee alertness effects - no peaberry-specific studies
• Rich in chlorogenic acids and caffeic acid detected at 310-350 nm wavelengths - biomedical effects unstudied
• Contains 22 phenolic compounds identified via mass spectrometry - health impacts not clinically evaluated
• Lower caffeine than regular coffee in some strains (~0.76 mg/g) - no clinical significance established

How It Works

Caffeine in peaberry Kona coffee blocks adenosine A1 and A2A receptors in the central nervous system, preventing drowsiness and promoting alertness. Chlorogenic acids may inhibit glucose-6-phosphatase and exhibit antioxidant activity through free radical scavenging. The caffeic acid component can modulate inflammatory pathways by inhibiting nuclear factor-κB activation.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on Peaberry Kona Coffee were identified in available sources, with no PMIDs found. Research focuses exclusively on analytical chemistry for bean authentication using UV-Vis spectroscopy and compound profiling rather than biomedical outcomes.

Clinical Summary

No clinical trials have specifically investigated peaberry Kona coffee's health effects. Research has been limited to analytical chemistry studies and authentication methods to verify origin and quality. The caffeine content and general coffee alertness effects are extrapolated from broader coffee research rather than peaberry-specific investigations. Current evidence consists primarily of laboratory analyses identifying bioactive compounds without human efficacy data.

Nutritional Profile

Peaberry Kona Coffee (green/roasted bean basis, per 100g dry mass unless noted): Caffeine ~1.2g/100g (12 mg/g dry mass, confirmed via HPLC authentication studies); Chlorogenic acids (CGAs) ~6-9g/100g total in green beans, reduced 50-70% upon roasting - primary isomers include 5-caffeoylquinic acid (5-CQA), 3-CQA, and 4-CQA detected at 310-350nm UV absorption; Caffeic acid present as both free form and esterified component of CGAs. Trigonelline ~0.6-1.0g/100g (precursor to niacin upon roasting). Total phenolic compounds: 22 identified phenolics via chromatographic profiling including hydroxycinnamic acid derivatives and flavonoid traces. Macronutrients (brewed coffee basis, 240ml): Calories ~2 kcal; Protein ~0.3g; Carbohydrates ~0g; Fat ~0g; Fiber negligible in liquid form. Minerals in brewed form: Potassium ~116mg/240ml; Magnesium ~7mg/240ml; Manganese ~0.1mg/240ml. Niacin (B3): ~0.5mg/240ml generated from trigonelline thermal conversion during roasting. Riboflavin (B2): trace ~0.01mg/240ml. Bioavailability notes: CGAs have moderate bioavailability (~30% absorbed in small intestine); caffeine bioavailability is near-complete (~99%); mineral absorption from coffee is partially inhibited by polyphenol-mineral chelation. No peaberry-specific nutritional differentiation from flat-bean Kona arabica has been documented in peer-reviewed literature - the single-seed morphology does not appear to alter gross compositional ratios, though bean density differences may concentrate some compounds marginally.

Preparation & Dosage

No clinically studied dosage ranges exist for Peaberry Kona Coffee in biomedical contexts. General Coffea arabica beans contain approximately 12 mg caffeine per gram dry mass, with low-caffeine strains containing ~0.76 mg/g. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Regular Coffea arabica, Green tea extract, L-theanine, Dark chocolate, Guarana

Safety & Interactions

Caffeine-sensitive individuals may experience jitteriness, insomnia, or increased heart rate from peaberry Kona coffee consumption. The caffeine content may interact with medications like warfarin, increasing bleeding risk, and may reduce absorption of iron and some antibiotics. Pregnant women should limit intake due to caffeine content potentially affecting fetal development. Those with anxiety disorders or cardiovascular conditions should consult healthcare providers before regular consumption.